Cargando…
The Novel Small Molecule STK899704 Promotes Senescence of the Human A549 NSCLC Cells by Inducing DNA Damage Responses and Cell Cycle Arrest
The novel synthetic compound designated STK899704 (PubChem CID: 5455708) suppresses the proliferation of a broad range of cancer cell types. However, the details of its effect on lung cancer cells are unclear. We investigated the precise anticancer effect of STK899704 on senescence and growth arrest...
Autores principales: | Park, Chan-Woo, Bak, Yesol, Kim, Min-Je, Srinivasrao, Ganipisetti, Hwang, Joonsung, Sung, Nak K., Kim, Bo Yeon, Yu, Jae-Hyuk, Hong, Jin Tae, Yoon, Do-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912185/ https://www.ncbi.nlm.nih.gov/pubmed/29713275 http://dx.doi.org/10.3389/fphar.2018.00163 |
Ejemplares similares
-
Anticancer activity of a novel small molecule tubulin inhibitor STK899704
por: Sakchaisri, Krisada, et al.
Publicado: (2017) -
STK899704 inhibits stemness of cancer stem cells and migration via the FAK-MEK-ERK pathway in HT29 cells
por: Jang, Hui-Ju, et al.
Publicado: (2018) -
STK295900, a Dual Inhibitor of Topoisomerase 1 and 2, Induces G(2) Arrest in the Absence of DNA Damage
por: Kim, Sun-Ok, et al.
Publicado: (2013) -
Correction: STK295900, a Dual Inhibitor of Topoisomerase 1 and 2, Induces G(2) Arrest in the Absence of DNA Damage
por: Kim, Sun-Ok, et al.
Publicado: (2013) -
STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world
por: Shire, Norah J., et al.
Publicado: (2020)